Neurological disorder

Neurogene Raises $68.5 Million in Series A Financing to Advance Multiple Programs in Devastating Neurological Diseases

Retrieved on: 
星期二, 二月 12, 2019
Health, Biotechnology, Clinical trials, Genetics, Pharmaceutical, Rare diseases, Neurological disorder, Medicine, Branches of biology

Neurogene, Inc ., a company founded with a mission to bring life-changing medicines to patients and families affected by rare neurological diseases, today announced a $68.5 million Series A financing.

Key Points: 
  • Neurogene, Inc ., a company founded with a mission to bring life-changing medicines to patients and families affected by rare neurological diseases, today announced a $68.5 million Series A financing.
  • Neurogene is reimagining the future for patients with rare neurological diseases and their families, said Rachel McMinn, Ph.D., Founder and Chief Executive Officer.
  • Through partnerships and our own internal expertise, we are advancing our gene therapy programs for rare neurological disorders.
  • The vast majority of rare diseases remain unaddressed, and our goal is to enable a better future for patients with these diseases.

Myomo Announces CFO Succession

Retrieved on: 
星期三, 二月 6, 2019
Technology, Other Technology, Health, Biotechnology, Medical devices, Physical therapy, Neurological disorder, Robotics

Myomo Inc. (NYSE American MYO) (Myomo, or the Company), a wearable medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis, today announced that Ralph A. Goldwasser, its Chief Financial Officer, is retiring effective as of February 18, 2019.

Key Points: 
  • Myomo Inc. (NYSE American MYO) (Myomo, or the Company), a wearable medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis, today announced that Ralph A. Goldwasser, its Chief Financial Officer, is retiring effective as of February 18, 2019.
  • Mr. Henry is joining Myomo from Eos Energy Storage, a privately held manufacturer of grid-scale energy storage systems for utilities and renewable project developers, where he has served as Chief Financial Officer since August 2017.
  • Myomo, Inc. is a wearable medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis.
  • Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. and a business development office in Europe.

Healthpointe Welcomes Newest Neurological and Pain Management Expert

Retrieved on: 
星期三, 一月 30, 2019
Neurological disorder, Neurology, Headache

Neurological symptoms vary and can include pain, numbness, mental confusion, headaches, and dizziness, all of which can significantly impact patients and their activities of daily living.

Key Points: 
  • Neurological symptoms vary and can include pain, numbness, mental confusion, headaches, and dizziness, all of which can significantly impact patients and their activities of daily living.
  • At Healthpointe, the neurologists utilize physiological principles and an understanding of human anatomy to best identify and treat the affected areas.
  • Dr. Rosario's career in neurology and pain management began in St. Louis, Missouri, where he graduated from St. Louis University with his Bachelor's Degree in Biology in 1975.
  • "I am certain that his vast experience in neurological science will prove to be an asset to our medical faculty."

Apptomics' Clinically Validated Digital Platform E.V.A Completes First Sub-Study for Essential Tremor

Retrieved on: 
星期二, 一月 8, 2019
Medicine, Biomarkers, Tremor, Biology, Essential tremor, Archimedean spiral, Neurological disorder

Recent enhancements to the platform include the addition of a digital spirography, a functional test of upper limb function used to objectively quantify tremor severity.

Key Points: 
  • Recent enhancements to the platform include the addition of a digital spirography, a functional test of upper limb function used to objectively quantify tremor severity.
  • E.V.A was used as an exploratory digital biomarker to evaluate treatment effects in a subpopulation in the recently completed essential tremor study.
  • Spiral drawings on paper like the Archimedes spiral have long been a common tremor evaluation tool for patients with essential tremor or Parkinson's disease.
  • Apptomics is a provider of clinically validated digital health solutions for patients living with chronic neurological conditions.

NEOFECT USA to Benefit from Korean IPO Debut

Retrieved on: 
星期四, 十一月 29, 2018
Neurological disorder, Musculoskeletal injury

SAN FRANCISCO, Nov. 29,2018 /PRNewswire/ --Korean-American med-tech company NEOFECT officially began trading on the KOSDAQ, securing more than $17 million in funding.

Key Points: 
  • SAN FRANCISCO, Nov. 29,2018 /PRNewswire/ --Korean-American med-tech company NEOFECT officially began trading on the KOSDAQ, securing more than $17 million in funding.
  • The Korean IPO will propel NEOFECT's U.S. operations, enabling the company to further expand its footprint in the U.S. and help more people with neurological and musculoskeletal injuries recover and improve their quality of life.
  • Over the past 18 months, NEOFECT expanded its direct-to-consumer market and has supported more than 700 consumers using its at-home solutions.
  • For more detailed information on NEOFECT, visit https://home.neofect.com
    Med-tech startup NEOFECT ( https://home.neofect.com ) helps stroke survivors and people with spinal cord injuries, musculoskeletal disorders, or neurological conditions regain independence and live fuller, more active lives.

MindMaze Acquires NMI

Retrieved on: 
星期三, 十一月 28, 2018
Tej Tadi, Neurology, Neurological disorder

MindMaze will further develop and commercializeNMI's technology that targets treatment of a wide range of neurological diseases and injuries from the acute through chronic stages.

Key Points: 
  • MindMaze will further develop and commercializeNMI's technology that targets treatment of a wide range of neurological diseases and injuries from the acute through chronic stages.
  • MindMaze acquires a perpetual license to NMI's technology, and the company will continue its close relationship with Johns Hopkins.
  • "This acquisition of the Neuro Motor Innovations technology and the team is a very significant deal for MindMaze and one that offers huge promise for patients with neurological diseases and injuries," said Tej Tadi, Founder, and CEO of MindMaze.
  • NMI is a medical technology company with a mission to improve movement and cognition outcomes in aging and neurology patients across the world.

Global Diagnostic Neuroimaging Markets and Emerging Applications, Forecast to 2022

Retrieved on: 
星期四, 八月 23, 2018
Radiology, Neuroimaging, Neurological disorder

What major imaging modalities make up the neuroimaging market and what is the proportion of imaging techniques used for diagnosis and treatment of key neurological disorders?

Key Points: 
  • What major imaging modalities make up the neuroimaging market and what is the proportion of imaging techniques used for diagnosis and treatment of key neurological disorders?
  • What is the estimated neuroimaging procedure volume and service market revenue of imaging technologies for different geographies like North America, Europe, and APAC?
  • How is the role of neuroimaging technologies and solutions in the diagnosis and treatment pathways for neurological disorders changing?
  • Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Researchers Discover Key Link to Understanding Sleep Disorders

Retrieved on: 
星期四, 七月 19, 2018
Neurological disorder, Sleep disorders

HERSHEY, Pa., July 19, 2018 /PRNewswire/ --Researchers have discovered a key link to potentially understanding sleep disorders in children, according to a study just published in the journal PLOS One.

Key Points: 
  • HERSHEY, Pa., July 19, 2018 /PRNewswire/ --Researchers have discovered a key link to potentially understanding sleep disorders in children, according to a study just published in the journal PLOS One.
  • The results of this groundbreaking research, funded by Quadrant Biosciences Inc. (Quadrant Biosciences), an emerging life science company based in Syracuse, New York, holds promise for advancing the diagnosis and treatment of sleep disorders among children.
  • Remarkably, the researchers found that while CircaMiRs and CircaMicrobes were accurate at predicting time of day in normal children and adults, the association broke down in children with sleep disorders.
  • "Alternatively, disruptions in miRNA-microbiome networks may unsettle the gut-brain-axis, a concept implicated in neurologic disorders such as Parkinson's and ASD, both of which are associated with disordered sleep."

UCB Announces Approval of NEUPRO® in China to Treat Parkinson's Disease

Retrieved on: 
星期一, 七月 2, 2018
Medicine, Medical terminology, Health, Parkinson's disease, UCB, Rotigotine, Disease, Chronic condition, Neurological disorder, Gevork Minaskanian

Parkinson's disease (PD) is a chronic, degenerative neurological disease with an estimated prevalence of 1.7% in China in people aged 65 years and older.

Key Points: 
  • Parkinson's disease (PD) is a chronic, degenerative neurological disease with an estimated prevalence of 1.7% in China in people aged 65 years and older.
  • [2]
    With this IDL, NEUPRO is now indicated in China for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's Disease as monotherapy (i.e.
  • NEUPRO is designed to support and improve individual patient treatment experiences for people living with Parkinson's Disease.
  • Alongside approval for NEUPRO, these activities reinforce UCB's ongoing commitment to supporting patients with severe diseases in China.

Advancing Neurostimulation Therapies for Optical Deficiencies Impacting Healthcare Industry in a Billion Dollar Way

Retrieved on: 
星期三, 六月 27, 2018
Medicine, Health, Neurotechnology, Electrotherapy, Medical devices, Neurological disorder, Neurology, Neurostimulation, Major trauma

Neurological devices available in the market can be classified into interventional neurology devices, CSF management devices, neurosurgical devices, and neurostimulation devices.

Key Points: 
  • Neurological devices available in the market can be classified into interventional neurology devices, CSF management devices, neurosurgical devices, and neurostimulation devices.
  • Leading the way in neurostimulation therapy are devices that treats neurological symptoms caused by disease and trauma as well as platforms dealing in treating the pandemic of binocular vision dysfunction.
  • Eyecarrot's Binovi Touch Saccadic Fixator will be available through Bernell and is showcased on the cover of their 2018 catalogue.
  • You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.